Carboxypeptidase E: A Protein Involved in Neurotransmitter Release and Disease

Target Name: CPE

NCBI ID: G1363

Content of Review Report on CPE Target / Biomarker

CPE

Carboxypeptidase E: A Protein Involved in Neurotransmitter Release and Disease

Carboxypeptidase E (CPE) is a protein that is expressed in various cell types of the human body, including the brain. It is a member of the superfamily of cysteine 鈥嬧?媝rotease family 2 (Cysteine 鈥嬧?媝rotease family 2) and is responsible for the breakdown of a specific protein called carboxypeptide.

CPE is expressed in the brain and has been shown to be involved in the regulation of neurotransmitter release and the modulation of pain perception. It is also involved in the regulation of inflammation and has been shown to play a role in the development of certain diseases, such as Alzheimer's disease and Parkinson's disease.

Recent studies have suggested that CPE may be a potential drug target or biomarker for a variety of diseases. For example, some studies have shown that inhibiting CPE may be effective in treating certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. Additionally, CPE has been shown to be involved in the regulation of pain perception and may be a useful biomarker for the diagnosis and treatment of chronic pain.

In addition to its potential clinical applications, CPE is also of interest to researchers because of its unique structure and mechanism of action. CPE is a member of the Cysteine 鈥嬧?媝rotease family 2 and consists of a single polypeptide chain that is made up of 111 amino acids . It has a unique catalytic mechanism of action, in which it uses a specific substrate to cleave a specific peptide bond, allowing it to break down a specific protein.

CPE has also been shown to have unique physiological functions. For example, it has been shown to be involved in the regulation of neurotransmitter release in the brain and to play a role in the regulation of inflammation. Additionally, CPE has been shown to be involved in the regulation of cell survival and has been shown to have anti-inflammatory effects.

In conclusion, CPE is a protein that is expressed in various cell types of the human body and is involved in the regulation of a wide range of physiological processes. Its unique structure and mechanism of action, as well as its involvement in the regulation of neurotransmitter release, inflammation, and cell survival, make it an attractive candidate for further research and potential clinical applications. Further studies are needed to fully understand the role of CPE in the regulation of various physiological processes and to determine its potential as a drug target or biomarker .

Protein Name: Carboxypeptidase E

Functions: Sorting receptor that directs prohormones to the regulated secretory pathway. Acts also as a prohormone processing enzyme in neuro/endocrine cells, removing dibasic residues from the C-terminal end of peptide hormone precursors after initial endoprotease cleavage

The "CPE Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CPE comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets